FDA clears Watson generic of Wellbutrin XL antidepressant

06/13/2007 | Forbes

Watson Pharmaceuticals says it has won FDA approval for its generic of Wellbutrin XL, the antidepressant made by Biovail and sold by GlaxoSmithKline. Watson said it plans to market its extended-release version immediately.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide